Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-020912
Filing Date
2024-01-31
Accepted
2024-01-31 16:05:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d575366ddefa14a.htm DEFA14A 19971
2 GRAPHIC g575366dsp002.jpg GRAPHIC 299005
3 GRAPHIC g575366dsp003.jpg GRAPHIC 210234
4 GRAPHIC g575366dsp004.jpg GRAPHIC 175055
5 GRAPHIC g575366dsp005.jpg GRAPHIC 153731
  Complete submission text file 0001193125-24-020912.txt   1166948
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38130 | Film No.: 24582902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)